"The development program for Arcoxia is fatally flawed"

November 13, 2006

Merck’s Vioxx replacement is off to a bad start.



Related posts:

  1. Flawed Medicare pay formula
  2. Arcoxia: Denied
  3. Arcoxia: Denied
  4. Implications of the Arcoxia rejection
  5. Get with the arbitration program
  6. When your hospitalist program collapses
  7. The demise of a liver transplant program


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Bad idea: Diagnosing over the phone leads a patient to be hospitalized

Next post: A plaintiff lawyer goes missing after settling a malpractice suit against his client’s wishes

Site Meter